BioMarin Pharmaceutical - 19 Year Stock Price History | BMRN

Historical daily share price chart and data for BioMarin Pharmaceutical since 1999 adjusted for splits and dividends. Open, high, low, close (OHLC) data as well as percentage changes for multiple date ranges. Display 20, 50 and 200 day moving averages and export charts as images to use in articles and blogs. The latest closing price for BioMarin Pharmaceutical as of November 13, 2018 is 93.52.
BioMarin Pharmaceutical Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2018 92.1952 91.0300 106.0700 76.0100 93.5200 4.88%
2017 88.8143 85.8400 98.8200 80.6000 89.1700 7.64%
2016 86.6998 104.9200 104.9200 64.7400 82.8400 -20.92%
2015 117.0456 92.1700 149.1300 90.2800 104.7600 15.88%
2014 70.7528 69.2700 94.1900 55.7800 90.4000 28.50%
2013 63.4324 51.9200 78.3880 51.5600 70.3500 42.99%
2012 39.1417 34.9300 50.1700 32.1300 49.2000 43.11%
2011 28.4184 26.6100 35.3800 23.4600 34.3800 27.66%
2010 22.1536 18.9500 28.2500 18.2400 26.9300 43.17%
2009 15.6685 17.6500 20.8300 10.1400 18.8100 5.67%
2008 29.7800 36.6400 40.3900 13.5900 17.8000 -49.72%
2007 21.0564 16.1000 36.5800 15.7100 35.4000 115.99%
2006 14.3090 10.9900 18.0400 10.9600 16.3900 52.04%
2005 7.3643 6.2600 11.4100 4.4300 10.7800 68.70%
2004 6.2104 7.9100 8.7900 3.8700 6.3900 -17.65%
2003 9.4456 7.0300 13.3200 6.4100 7.7600 10.07%
2002 7.2827 13.2400 13.9500 3.6500 7.0500 -47.54%
2001 11.0435 9.5000 14.1600 7.3130 13.4400 38.73%
2000 18.0555 12.7500 38.7500 7.1560 9.6880 -17.55%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $16.572B $1.314B
BioMarin Pharmaceutical Inc. is a developer of carbohydrate enzyme therapies for debilitating, life-threatening, chronic genetic disorders and other diseases and conditions. The company completed a six-month evaluation of patients being treated with BioMarin's lead product, BM101, for the treatment of mucopolysaccharidosis-I, or MPS-I. Patients were treated with BM101 as part of a pivotal clinical trial completed to determine the safety and efficacy of the drug in humans.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $122.066B 13.80
Gilead Sciences (GILD) United States $91.187B 10.98
Biogen (BIIB) United States $64.253B 13.01
Celgene (CELG) United States $49.661B 9.64
Illumina (ILMN) United States $45.627B 53.15
Vertex Pharmaceuticals (VRTX) United States $44.173B 77.17
Regeneron Pharmaceuticals (REGN) United States $37.448B 19.00
Alexion Pharmaceuticals (ALXN) United States $26.459B 18.11
Incyte (INCY) United States $13.377B 369.77
Seattle Genetics (SGEN) United States $8.805B 0.00
Exact Sciences (EXAS) United States $8.388B 0.00
Sarepta Therapeutics (SRPT) United States $8.074B 0.00
Bio-Rad Laboratories (BIO.B) United States $8.015B 51.25
QIAGEN (QGEN) Netherlands $8.006B 25.61
Alnylam Pharmaceuticals (ALNY) United States $6.862B 0.00
Bluebird Bio (BLUE) United States $6.541B 0.00
Bio-Techne Corp (TECH) United States $6.181B 41.75
BeiGene (BGNE) Cayman Islands $5.950B 0.00
Amarin (AMRN) Ireland $5.794B 0.00
Alkermes (ALKS) Ireland $5.392B 3470.00
Galapagos (GLPG) Belgium $5.218B 0.00
Exelixis (EXEL) United States $4.763B 13.50
Immunomedics (IMMU) United States $3.890B 0.00
Horizon Pharma Public (HZNP) Ireland $3.644B 14.99
MorphoSys AG Unsponsored ADR (MOR) Germany $3.535B 0.00
Emergent Biosolutions (EBS) United States $3.347B 28.19
Ligand Pharmaceuticals (LGND) United States $3.281B 25.28
Guardant Health (GH) United States $3.269B 0.00
Array BioPharma (ARRY) United States $3.217B 0.00
Allogene Therapeutics (ALLO) United States $3.113B 0.00
Intercept Pharmaceuticals (ICPT) United States $2.988B 0.00
ARGENX SE-ADR (ARGX) Netherlands $2.981B 0.00
Repligen (RGEN) United States $2.864B 89.44
Genomic Health (GHDX) United States $2.855B 97.10
Blueprint Medicines (BPMC) United States $2.624B 0.00
Ascendis Pharma (ASND) Denmark $2.532B 0.00
Ultragenyx Pharmaceutical (RARE) United States $2.483B 0.00
Acceleron Pharma (XLRN) United States $2.385B 0.00
ACADIA Pharmaceuticals (ACAD) United States $2.359B 0.00
Allakos (ALLK) United States $2.351B 0.00
Akcea Therapeutics (AKCA) United States $2.327B 0.00
China Biologic Products (CBPO) China $2.321B 16.52
MyoKardia (MYOK) United States $2.255B 0.00
REGENXBIO (RGNX) United States $2.248B 30.15
Myriad Genetics (MYGN) United States $2.217B 21.97
Halozyme Therapeutics (HALO) United States $2.183B 48.71
Global Blood Therapeutics (GBT) United States $2.018B 0.00
Amicus Therapeutics (FOLD) United States $1.914B 0.00
AnaptysBio (ANAB) United States $1.889B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $1.877B 0.00
Reata Pharmaceuticals (RETA) United States $1.865B 0.00
Arena Pharmaceuticals (ARNA) United States $1.683B 0.00
Medicines (MDCO) United States $1.650B 0.00
Aimmune Therapeutics (AIMT) United States $1.642B 0.00
Cambrex (CBM) United States $1.636B 12.22
Innoviva (INVA) United States $1.631B 9.22
G1 THERAPEUTICS (GTHX) United States $1.609B 0.00
Denali Therapeutics (DNLI) United States $1.583B 0.00
Spark Therapeutics (ONCE) United States $1.572B 0.00
NeoGenomics (NEO) United States $1.547B 127.92
Atara Biotherapeutics (ATRA) United States $1.542B 0.00
Biohaven Pharmaceutical Holding (BHVN) United States $1.463B 0.00
Autolus Therapeutics Sponsored ADR (AUTL) United Kingdom $1.377B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $1.363B 0.00
Editas Medicine (EDIT) United States $1.348B 0.00
IMMURON LTD (IMRN) Australia $1.294B 0.00
Mirati Therapeutics (MRTX) United States $1.249B 0.00
Myovant Sciences (MYOV) United Kingdom $1.247B 0.00
Insmed (INSM) United States $1.237B 0.00
ORCHARD THERAPT (ORTX) United Kingdom $1.219B 0.00
Vanda Pharmaceuticals (VNDA) United States $1.186B 94.25
Rubius Therapeutics (RUBY) United States $1.164B 0.00
WAVE Life Sciences (WVE) Singapore $1.163B 0.00
Cellectis (CLLS) France $1.073B 0.00
Momenta Pharmaceuticals (MNTA) United States $1.033B 0.00
Solid Biosciences (SLDB) United States $1.024B 0.00
Retrophin (RTRX) United States $1.022B 0.00
Sangamo Therapeutics (SGMO) United States $1.017B 0.00
DBV Technologies (DBVT) France $1.010B 0.00
Audentes Therapeutics (BOLD) United States $1.007B 0.00
Intra-Cellular Therapies (ITCI) United States $0.977B 0.00
Zai Lab Unsponsored ADR (ZLAB) China $0.955B 0.00
Rhythm Pharmaceuticals (RYTM) United States $0.940B 0.00
Kiniksa Pharmaceuticals (KNSA) Bermuda $0.905B 0.00
Alder BioPharmaceuticals (ALDR) United States $0.903B 0.00
Lion Biotechnologies (IOVA) United States $0.897B 0.00
UniQure (QURE) Netherlands $0.894B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.888B 0.00
Acorda Therapeutics (ACOR) United States $0.875B 11.08
Aptinyx (APTX) United States $0.856B 0.00
Puma Biotechnology (PBYI) United States $0.844B 0.00
Dicerna Pharmaceuticals (DRNA) United States $0.841B 0.00
Fate Therapeutics (FATE) United States $0.839B 0.00
Viking Therapeutics (VKTX) United States $0.838B 0.00
Revance Therapeutics (RVNC) United States $0.837B 0.00
Apellis Pharmaceuticals (APLS) United States $0.828B 0.00
Deciphera Pharmaceuticals (DCPH) United States $0.789B 0.00
Athenex (ATNX) United States $0.778B 0.00
Clovis Oncology (CLVS) United States $0.763B 0.00
Dynavax Technologies (DVAX) United States $0.763B 0.00
Heska (HSKA) United States $0.762B 62.36
Intellia Therapeutics (NTLA) United States $0.751B 0.00
Coherus BioSciences (CHRS) United States $0.745B 0.00
Cara Therapeutics (CARA) United States $0.743B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.717B 0.00
InflaRx (IFRX) Germany $0.710B 0.00
Vericel (VCEL) United States $0.695B 0.00
AVROBIO (AVRO) United States $0.678B 0.00
Novavax (NVAX) United States $0.655B 0.00
UROGEN PHARMA (URGN) Israel $0.628B 0.00
CytomX Therapeutics (CTMX) United States $0.622B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.621B 0.00
ANI Pharmaceuticals (ANIP) United States $0.621B 11.90
Inotek Pharmaceuticals (RCKT) United States $0.612B 0.00
Gritstone Oncology (GRTS) United States $0.601B 0.00
TWIST BIOSCIENC (TWST) $0.599B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.597B 0.00
Epizyme (EPZM) United States $0.593B 0.00
Senesco Technologies (ELOX) United States $0.590B 0.00
Scholar Rock Holding (SRRK) United States $0.585B 0.00
NuCana Sponsored ADR (NCNA) United Kingdom $0.574B 0.00
Principia Biopharma (PRNB) United States $0.573B 0.00
AC Immune SA (ACIU) Switzerland $0.570B 0.00
ObsEva SA (OBSV) Switzerland $0.541B 0.00
Eidos Therapeutics (EIDX) United States $0.537B 0.00
Arcus Biosciences (RCUS) United States $0.533B 0.00
Arvinas (ARVN) United States $0.523B 0.00
Mesoblast (MESO) Australia $0.516B 0.00
UNITY Biotechnology (UBX) $0.508B 0.00
Anika Therapeutics (ANIK) United States $0.505B 20.91
Kezar Life Sciences (KZR) United States $0.500B 0.00
BeyondSpring (BYSI) United States $0.462B 0.00
Prothena (PRTA) Ireland $0.453B 0.00
Inovio Pharmaceuticals (INO) United States $0.450B 0.00
Replimune (REPL) United States $0.448B 0.00
Kindred Biosciences (KIN) United States $0.436B 0.00
Kura Oncology (KURA) United States $0.436B 0.00
Sinovac Biotech (SVA) China $0.434B 0.00
Clementia Pharmaceuticals (CMTA) Canada $0.430B 0.00
Zymeworks (ZYME) Canada $0.429B 0.00
PDL BioPharma (PDLI) United States $0.415B 6.76
Sorrento Therapeutics (SRNE) United States $0.407B 69.80
MediciNova (MNOV) United States $0.400B 0.00
Five Prime Therapeutics (FPRX) United States $0.398B 0.00
Stemline Therapeutics (STML) United States $0.391B 0.00
Achillion Pharmaceuticals (ACHN) United States $0.377B 0.00
RA PHARMCTL INC (RARX) United States $0.375B 0.00
Verastem (VSTM) United States $0.375B 0.00
Abeona Therapeutics (ABEO) United States $0.370B 0.00
Zealand Pharma (ZEAL) Denmark $0.369B 0.00
Cytokineticsorporated (CYTK) United States $0.362B 0.00
Osiris Therapeutics (OSIR) United States $0.361B 0.00
MeiraGTx Holdings (MGTX) United States $0.354B 0.00
Nightstar Therapeutics Sponsored ADR (NITE) United States $0.332B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.330B 0.00
Seres Therapeutics (MCRB) United States $0.327B 0.00
ResTORbio (TORC) United States $0.317B 0.00
Merus (MRUS) Netherlands $0.313B 0.00
Krystal Biotech (KRYS) United States $0.312B 0.00
Sutro Biopharma (STRO) United States $0.310B 0.00
Cellular Biomedicine (CBMG) United States $0.307B 0.00
LogicBio Therapeutics (LOGC) United States $0.301B 0.00
Keryx Biopharmaceuticals (KERX) United States $0.296B 0.00
MannKind (MNKD) United States $0.294B 0.00
Kodiak Sciences (KOD) United States $0.293B 0.00
Geron (GERN) United States $0.293B 0.00
Albireo Pharma (ALBO) United States $0.292B 0.00
Liquidia Technologies (LQDA) United States $0.289B 0.00
Aduro Biotech (ADRO) United States $0.284B 0.00
Biofrontera AG Sponsored ADR (BFRA) Germany $0.284B 0.00
Celcuity (CELC) United States $0.281B 0.00
Kadmon Holdings (KDMN) United States $0.277B 0.00
Peregrine Pharmaceuticals (CDMO) United States $0.277B 0.00
Celyad SA (CYAD) Belgium $0.275B 0.00
Athersys (ATHX) United States $0.269B 0.00
Equillium (EQ) United States $0.261B 0.00
Magenta Therapeutics (MGTA) United States $0.261B 0.00
BioDelivery Sciences (BDSI) United States $0.258B 0.00
Syros Pharmaceuticals (SYRS) United States $0.252B 0.00
Arbutus Biopharma (ABUS) Canada $0.246B 0.00
Strongbridge Biopharma (SBBP) United States $0.245B 0.00
Evelo Biosciences (EVLO) United States $0.244B 0.00
GAMIDA CELL LTD (GMDA) $0.243B 0.00
Proteostasis Therapeutics (PTI) United States $0.242B 0.00
ADMA Biologics Inc (ADMA) United States $0.239B 0.00
Axovant Sciences (AXON) United Kingdom $0.238B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.238B 0.00
Urovant Sciences (UROV) United States $0.235B 0.00
Adverum Biotechnologies (ADVM) United States $0.233B 0.00
TOCAGEN INC (TOCA) United States $0.232B 0.00
Agenus (AGEN) United States $0.230B 0.00
Protagonist Therapeutics (PTGX) United States $0.227B 0.00
Kamada (KMDA) Israel $0.223B 20.56
Corvus Pharmaceuticals (CRVS) United States $0.220B 0.00
Kala Pharmaceuticals (KALA) United States $0.219B 0.00
Idera Pharmaceuticals (IDRA) United States $0.216B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.214B 0.00
BioTime (BTX) United States $0.213B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.210B 0.00
Sienna Biopharmaceuticals (SNNA) United States $0.206B 0.00
Unum Therapeutics (UMRX) United States $0.203B 0.00
Synlogic (SYBX) United States $0.197B 0.00
Intec Pharma (NTEC) Israel $0.193B 0.00
ChromaDex (CDXC) United States $0.190B 0.00
NantKwest (NK) United States $0.187B 0.00
Palatin Technologies (PTN) United States $0.187B 7.71
ASLAN Pharmaceuticals (ASLN) Singapore $0.179B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.178B 0.00
Spring Bank Pharmaceuticals (SBPH) United States $0.172B 0.00
Cerecor (CERC) United States $0.163B 16.67
Compugen (CGEN) Israel $0.161B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.161B 0.00
Menlo Therapeutics (MNLO) United States $0.160B 0.00
PSivida (EYPT) United States $0.160B 0.00
Allena Pharmaceuticals (ALNA) United States $0.159B 0.00
Cohbar (CWBR) United States $0.159B 0.00
Pfenex (PFNX) United States $0.159B 0.00
Spero Therapeutics (SPRO) United States $0.154B 0.00
Enzo Biochem (ENZ) United States $0.151B 0.00
Constellation Pharmaceuticals (CNST) United States $0.146B 0.00
XBiotech (XBIT) United States $0.144B 0.00
Eiger BioPharmaceuticals (EIGR) United States $0.143B 0.00
Verona Pharma American Depositary Share (VRNA) United Kingdom $0.138B 0.00
Pluristem Therapeutics (PSTI) Israel $0.135B 0.00
Mersana Therapeutics (MRSN) United States $0.135B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.134B 0.00
Eleven Biotherapeutics (SESN) United States $0.133B 0.00
Erytech Pharma SA Sponsored ADR (ERYP) France $0.130B 0.00
Organovo Holdings (ONVO) United States $0.129B 0.00
Applied Genetic Technologies (AGTC) United States $0.128B 0.00
Catalyst Biosciences (CBIO) United States $0.128B 0.00
Mustang Bio (MBIO) United States $0.125B 0.00
Cue Biopharma (CUE) United States $0.123B 0.00
VBI Vaccines (VBIV) United States $0.123B 0.00
CorMedix Inc (CRMD) United States $0.122B 0.00
Selecta Biosciences (SELB) United States $0.121B 0.00
XOMA (XOMA) United States $0.120B 0.00
OVID THERAPEUTC (OVID) United States $0.117B 0.00
Anavex Life Sciences (AVXL) United States $0.114B 0.00
PHASEBIO PHARMA (PHAS) United States $0.113B 0.00
Cidara Therapeutics (CDTX) United States $0.113B 0.00
Signal Genetics (MGEN) United States $0.112B 0.00
Motif Bio Plc (MTFB) United States $0.110B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.106B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.098B 0.00
Chiasma (CHMA) United States $0.097B 0.00
Provention Bio (PRVB) United States $0.096B 0.00
ScPharmaceuticals (SCPH) United States $0.094B 0.00
Orgenesis (ORGS) United States $0.092B 0.00
Monster Digital (INNT) United States $0.091B 0.00
Ophthotech (OPHT) United States $0.089B 0.00
VolitionRX (VNRX) Singapore $0.089B 0.00
Neothetics (EVFM) United States $0.088B 0.00
BioXcel Therapeutics (BTAI) United States $0.087B 0.00
Axsome Therapeutics (AXSM) United States $0.087B 0.00
VTv Therapeutics (VTVT) United States $0.083B 0.00
Prima BioMed (IMMP) Australia $0.081B 0.00
Cel-Sci (CVM) United States $0.079B 0.00
Aptose Biosciences (APTO) Canada $0.078B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.076B 0.00
Alcobra (ARCT) United States $0.074B 0.00
Aptevo Therapeutics (APVO) United States $0.074B 0.00
NewLink Genetics (NLNK) United States $0.074B 0.00
Checkpoint Therapeutics (CKPT) United States $0.073B 0.00
Vaccinex (VCNX) United States $0.071B 0.00
Evogene (EVGN) Israel $0.070B 0.00
Alimera Sciences (ALIM) United States $0.070B 0.00
Bionano Genomics (BNGO) United States $0.070B 0.00
Asterias Biotherapeutics (AST) United States $0.070B 0.00
ITUS (ANIX) United States $0.068B 0.00
Oncobiologics (ONS) United States $0.064B 0.00
Brainstorm Cell Therapeutics (BCLI) United States $0.063B 0.00
Protalix BioTherapeutics (PLX) Israel $0.062B 0.00
VistaGen Therapeutics (VTGN) United States $0.061B 0.00
Cocrystal Pharma (COCP) United States $0.061B 68.33
Entera Bio (ENTX) Israel $0.060B 0.00
Sophiris Bio (SPHS) United States $0.059B 0.00
Bellerophon Therapeutics (BLPH) United States $0.059B 0.00
Merrimack Pharmaceuticals (MACK) United States $0.059B 0.00
Leap Therapeutics (LPTX) United States $0.058B 0.00
Celldex Therapeutics (CLDX) United States $0.058B 0.00
OncoMed Pharmaceuticals (OMED) United States $0.057B 9.25
Fortress Biotech (FBIO) United States $0.057B 0.00
Clearside Biomedical (CLSD) United States $0.055B 0.00
Trevena (TRVN) United States $0.055B 0.00
OncoSec Medical (ONCS) United States $0.051B 0.00
Caladrius Biosciences (CLBS) United States $0.050B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.048B 0.00
Curis (CRIS) United States $0.048B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.046B 0.00
Vascular Biogenics (VBLT) Israel $0.046B 0.00
Zosano Pharma (ZSAN) United States $0.045B 0.00
Oncolytics Biotech (ONCY) Canada $0.045B 0.00
Rexahn Pharmaceuticals (RNN) United States $0.043B 0.00
TRACON Pharmaceuticals (TCON) United States $0.041B 0.00
Galena Biopharma (SLS) United States $0.041B 0.00
AquaBounty Technologies (AQB) United States $0.040B 0.00
AEterna Zentaris (AEZS) United States $0.040B 7.53
Versartis (ARAV) United States $0.039B 6.39
BiondVax Pharmaceuticals (BVXV) Israel $0.039B 0.00
AZURRX BIOPHARM (AZRX) United States $0.038B 0.00
Celsion (CLSN) United States $0.038B 0.00
VIVUS (VVUS) United States $0.036B 0.00
GTx (GTXI) United States $0.036B 0.00
Moleculin Biotech (MBRX) United States $0.036B 0.00
BioPharmX (BPMX) United States $0.034B 0.00
Proteon Therapeutics (PRTO) United States $0.034B 0.00
Eyenovia (EYEN) United States $0.031B 0.00
Advaxis (ADXS) United States $0.028B 0.00
Therapix Biosciences (TRPX) Israel $0.027B 10.21
Vical (VICL) United States $0.027B 0.00
Aileron Therapeutics (ALRN) United States $0.027B 0.00
Novelion Therapeutics (NVLN) Canada $0.026B 0.00
OvaScience (OVAS) United States $0.026B 0.00
Benitec Biopharma (BNTC) Australia $0.026B 0.00
Cellect Biotechnology (APOP) Israel $0.025B 0.00
CytRx (CYTR) United States $0.024B 0.00
GENPREX INC (GNPX) United States $0.023B 0.00
Akari Therapeutics (AKTX) United Kingdom $0.022B 0.00
Edge Therapeutics (EDGE) United States $0.021B 0.00
Pulmatrix (PULM) United States $0.019B 0.00
Cleveland BioLabs (CBLI) United States $0.019B 0.00
Arsanis (ASNS) United States $0.019B 0.00
Genetic Technologies (GENE) Australia $0.019B 0.00
ATyr Pharma (LIFE) United States $0.018B 0.00
Fibrocell Science Inc (FCSC) United States $0.018B 0.00
TrovaGene (TROV) United States $0.018B 0.00
Gemphire Therapeutics (GEMP) United States $0.017B 0.00
RestorGenex (DFFN) United States $0.017B 0.00
Soligenix (SNGX) United States $0.017B 0.00
Prana Biotechnology (PRAN) Australia $0.015B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.014B 0.00
Histogenics (HSGX) United States $0.014B 0.00
IBio (IBIO) United States $0.014B 0.00
Vital Therapies (VTL) United States $0.014B 0.00
Novogen (KZIA) Australia $0.013B 0.00
Oragenics (OGEN) United States $0.011B 0.00
Cerulean Pharma (DARE) United States $0.010B 0.00
Hemispherx BioPharma (HEB) United States $0.010B 0.00
ARCA Biopharma (ABIO) United States $0.010B 0.00
AmpliPhi Biosciences (APHB) United States $0.010B 0.00
Adial Pharmaceuticals (ADIL) United States $0.009B 0.00
Titan Pharmaceuticals (TTNP) United States $0.009B 0.00
Alliqua BioMedical (ALQA) United States $0.009B 0.00
Flex Pharma (FLKS) United States $0.008B 0.00
MYOS RENS Technology (MYOS) United States $0.008B 0.00
Neuralstem (CUR) United States $0.008B 0.00
ContraVir Pharmaceuticals Inc (CTRV) United States $0.008B 0.00
Synthetic Biologics (SYN) United States $0.006B 0.00
Tenax Therapeutics (TENX) United States $0.006B 0.00
Stellar Biotechnologies (SBOT) United States $0.006B 0.00
Cytori Therapeutics Inc (CYTX) United States $0.003B 0.00
Aytu Bioscience (AYTU) United States $0.002B 0.00
OSMOTICA PHARM (OSMT) United States $0.000B 0.00
Y-mAbs Therapeutics (YMAB) United States $0.000B 0.00